Cyclin D1和p16在肥大乳房腺体组织中的表达及意义(4)
 |
| 第1页 |
参见附件(2286KB，4页)。
[12]Umekita Y, Ohi Y, Sagara Y, et al. Overexpression of cyclinD1 predicts for poor prognosis in estrogen receptor-negative breast cancer patients[J]. Int J Cancer,2002,98(3):415-418.
[13]Kii T,Takiuchi H,Kawabe S,et al. Evaluation of prognostic factors of esophageal squamous cell carcinoma (stage II-III) after concurrent chemo-radio therapy using biopsy specimens[J]. Jpn J Clin Oncol. 2007 Aug; 37(8): 583-589.
[14]Caldon CE,Daly RJ,Sutherland RL,et al. Cell cycle control in breast cancer cells[J].J Cell Biochem,2006,97(2):261-274.
[15]官亮,黄缘,朱水山. 原发性小肠腺癌p16蛋白及PCNA的表达[J].山东医药,2008,48(42): 16-18.
[16]Sirera R, Gil M, Blasco A, Cabrera A, et al. Retrospective analysis of the prognostic role of p16 protein inactivation in plasma in patients with locally advanced non-small cell lung cancer[J]. Lung Cancer,2008,61(1):104-108.
[17]Tieju Liu MD,Yun Niu MD,Yumei Feng PHD,et al. Methylation of CpG islands of p16INK4 and cyclinD1 overexpression associated with progression of intraductal proliferative lesions of the breast[J]. Human Pathology,2008,39:1637-1646.
[18]Alt JR, Gladden AB, Diehl JA ......
您现在查看是摘要介绍页，详见PDF附件(2286KB，4页)。